Package 72189-582-60

Brand: buprenorphine sublingual c-iii

Generic: buprenorphine sublingual c-iii
NDC Package

Package Facts

Identity

Package NDC 72189-582-60
Digits Only 7218958260
Product NDC 72189-582
Product ID 72189-582_248524c6-4c8c-a450-e063-6394a90a81ef
Description

60 TABLET in 1 BOTTLE (72189-582-60)

Marketing

Marketing Status
Marketed Since 2024-10-15
Brand buprenorphine sublingual c-iii
Generic buprenorphine sublingual c-iii
Sample Package No

Linked Drug Pages (1)

Buprenorphine Sublingual C-III ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBLINGUAL"], "spl_id": "248524c6-4c8c-a450-e063-6394a90a81ef", "openfda": {"unii": ["56W8MW3EN1"], "rxcui": ["351265"], "spl_set_id": ["248524c6-4c8b-a450-e063-6394a90a81ef"], "manufacturer_name": ["Direct_Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (72189-582-60)", "package_ndc": "72189-582-60", "marketing_start_date": "20241015"}], "brand_name": "Buprenorphine Sublingual C-III", "product_id": "72189-582_248524c6-4c8c-a450-e063-6394a90a81ef", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "72189-582", "dea_schedule": "CIII", "generic_name": "Buprenorphine Sublingual C-III", "labeler_name": "Direct_Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine Sublingual C-III", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA078633", "marketing_category": "ANDA", "marketing_start_date": "20241015", "listing_expiration_date": "20261231"}